Misook Yu

Array ( [id] => 968405 [patent_doc_number] => 06939679 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-09-06 [patent_title] => 'NADE binding proteins' [patent_app_type] => utility [patent_app_number] => 09/661305 [patent_app_country] => US [patent_app_date] => 2000-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7356 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/939/06939679.pdf [firstpage_image] =>[orig_patent_app_number] => 09661305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1196432 [patent_doc_number] => 06727080 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-27 [patent_title] => 'Gene encoding labyrinthin, a marker for cancer' [patent_app_type] => B1 [patent_app_number] => 09/659521 [patent_app_country] => US [patent_app_date] => 2000-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9504 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/727/06727080.pdf [firstpage_image] =>[orig_patent_app_number] => 09659521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1046829 [patent_doc_number] => 06864224 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-08 [patent_title] => 'Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth' [patent_app_type] => utility [patent_app_number] => 09/654281 [patent_app_country] => US [patent_app_date] => 2000-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 13 [patent_no_of_words] => 25542 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/864/06864224.pdf [firstpage_image] =>[orig_patent_app_number] => 09654281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 793106 [patent_doc_number] => 06982151 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-03 [patent_title] => 'Design of novel assays based on the newly found role of dystroglycan and alpha-dystroglycan proteolysis in tumor cell growth' [patent_app_type] => utility [patent_app_number] => 09/652493 [patent_app_country] => US [patent_app_date] => 2000-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 12 [patent_no_of_words] => 6275 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/982/06982151.pdf [firstpage_image] =>[orig_patent_app_number] => 09652493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 772768 [patent_doc_number] => 07001600 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-21 [patent_title] => 'Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes' [patent_app_type] => utility [patent_app_number] => 09/651210 [patent_app_country] => US [patent_app_date] => 2000-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12685 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/001/07001600.pdf [firstpage_image] =>[orig_patent_app_number] => 09651210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 551686 [patent_doc_number] => 07160677 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-01-09 [patent_title] => 'Transcription factor DP-1' [patent_app_type] => utility [patent_app_number] => 09/645572 [patent_app_country] => US [patent_app_date] => 2000-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 31 [patent_no_of_words] => 15858 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/160/07160677.pdf [firstpage_image] =>[orig_patent_app_number] => 09645572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 982359 [patent_doc_number] => 06927203 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-09 [patent_title] => 'Treatment of metastatic disease' [patent_app_type] => utility [patent_app_number] => 09/640935 [patent_app_country] => US [patent_app_date] => 2000-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 6 [patent_no_of_words] => 5960 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/927/06927203.pdf [firstpage_image] =>[orig_patent_app_number] => 09640935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 707834 [patent_doc_number] => 07060667 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-13 [patent_title] => 'Treatment of follicular lymphomas using inhibitors of the LT pathway' [patent_app_type] => utility [patent_app_number] => 09/626219 [patent_app_country] => US [patent_app_date] => 2000-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8051 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060667.pdf [firstpage_image] =>[orig_patent_app_number] => 09626219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1107451 [patent_doc_number] => 06808924 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-26 [patent_title] => 'Mouse mammary tumor lines expressing estrogen and progesterone receptors' [patent_app_type] => B1 [patent_app_number] => 09/613707 [patent_app_country] => US [patent_app_date] => 2000-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 7517 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/808/06808924.pdf [firstpage_image] =>[orig_patent_app_number] => 09613707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 484663 [patent_doc_number] => 07217421 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-05-15 [patent_title] => 'Cancer-associated antigens and methods of their identification and use' [patent_app_type] => utility [patent_app_number] => 09/610891 [patent_app_country] => US [patent_app_date] => 2000-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 14895 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/217/07217421.pdf [firstpage_image] =>[orig_patent_app_number] => 09610891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 733444 [patent_doc_number] => 07038028 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-02 [patent_title] => 'Gene encoding promoter domain of tumor suppressor gene P51 and use thereof' [patent_app_type] => utility [patent_app_number] => 10/030294 [patent_app_country] => US [patent_app_date] => 2000-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9360 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/038/07038028.pdf [firstpage_image] =>[orig_patent_app_number] => 10030294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 645067 [patent_doc_number] => 07118889 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-10 [patent_title] => 'Protein tyrosine kinase substrate LAT and its use in the indentification of (ant)agonists of the kinase' [patent_app_type] => utility [patent_app_number] => 09/597920 [patent_app_country] => US [patent_app_date] => 2000-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 46 [patent_no_of_words] => 32253 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/118/07118889.pdf [firstpage_image] =>[orig_patent_app_number] => 09597920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 979171 [patent_doc_number] => 06930175 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-16 [patent_title] => 'Gene family with transformation modulating activity' [patent_app_type] => utility [patent_app_number] => 09/591500 [patent_app_country] => US [patent_app_date] => 2000-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 14 [patent_no_of_words] => 16240 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/930/06930175.pdf [firstpage_image] =>[orig_patent_app_number] => 09591500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1059601 [patent_doc_number] => 06852691 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-08 [patent_title] => 'Anti-angiogenic peptides and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 09/589777 [patent_app_country] => US [patent_app_date] => 2000-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 41 [patent_no_of_words] => 25235 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/852/06852691.pdf [firstpage_image] =>[orig_patent_app_number] => 09589777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 383191 [patent_doc_number] => 07307143 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-12-11 [patent_title] => 'Conductin protein and a related agent for diagnosing and treating tumor illnesses' [patent_app_type] => utility [patent_app_number] => 09/587574 [patent_app_country] => US [patent_app_date] => 2000-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 1910 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/307/07307143.pdf [firstpage_image] =>[orig_patent_app_number] => 09587574 [rel_patent_id] =>[rel_patent_doc_number] =>)